Control Group: Patients Take Biomedical Research into Their Own Hands
Friday, July 9, 2010 - 09:28
in Health & Medicine
Cathy Wolf read the report carefully. She had every right to be skeptical--in the 13 years since her amyotrophic lateral sclerosis diagnosis, she'd read dozens like it: Celebrex ; minocycline; vitamin D--you name it, it could slow the progress of ALS . That is until it was tested in a clinical trial. [More] Amyotrophic lateral sclerosis - Clinical trial - Health - Neurological Disorders - Conditions and Diseases